For example, in preclinical models of systemic lupus erythematosus (SLE), anti-CD19 CAR-Tregs were able to suppress B-cell proliferation and activity and limit the generation of autoantibodies, thereby creating a tolerance-inducing microenvironment [109]. The gene discussed is CD19; the disease is systemic lupus erythematosus.